IkT-001Pro

· Inhibikase Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IkT-001Pro, covering 2025-06-13 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg [Phase 1]